| Financial Year |
March 31 2023 |
| Monetary Funds |
567,386,979.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
3,148,215.41 |
| Advances to Suppliers |
5,041,949.88 |
| Other Receivables |
15,539,623.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,804,660.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,409,482.68 |
| Total Current Assets |
608,576,812.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,976,103.36 |
| Investment Properties |
-- |
| Fixed Assetes |
438,896,164.06 |
| Under-construction Projects |
2,592,714.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,711,644.08 |
| R&D expenses |
-- |
| Goodwill |
17,004,532.78 |
| Long-Term Deferred and Prepaid Expenses |
16,537,948.31 |
| Deferred Income Tax Assets |
5,736,972.17 |
| Other Non-Current Assets |
307,019,798.12 |
| Sub-Total of Non-Current Assets |
823,390,062.49 |
| Total Assets |
1,431,966,875.19 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
321,489,000.00 |
| Accounts Payable |
9,604,742.46 |
| Accounts Received In Advance |
200,000,000.00 |
| Employee Compensation Payable |
15,523,317.08 |
| Taxes Payable |
5,338,920.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,006,615.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,970,081.73 |
| Other Current Liabilities |
26,422,785.29 |
| Sub-Total of Current Liabilities |
662,599,529.37 |
| Long-term Loans |
254,200,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
7,502,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
240,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
268,818,425.01 |
| Total Liabilities |
931,417,954.38 |
| Paid-In Capital(Or Share Stock) |
365,698,690.00 |
| Capital Surplus |
544,268,611.96 |
| Surplus Reserve |
18,214,273.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-664,128,708.90 |
| Minority Stockholder's Interest |
250,027,996.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
250,520,924.08 |
| Owner's Equity（Stockholder's Equity） |
500,548,920.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,431,966,875.19 |
